Trial Outcomes & Findings for Deep-Learning Image Reconstruction in CCTA (NCT NCT03980470)
NCT ID: NCT03980470
Last Updated: 2021-11-24
Results Overview
Subjective image quality as measured by Likert scale from 1 (non-evaluable) to 5 (excellent)
COMPLETED
NA
50 participants
Day 1
2021-11-24
Participant Flow
Recruitment period: 08/May/2019 until 20/June/2019 Location: University Hospital Zurich, Department of Nuclear Medicine, Switzerland
Participant milestones
| Measure |
Normal-dose Versus Low-dose
The standard intervention consists of the routinely performed cardiac CT datasets reconstructed with a standard iterative reconstruction algorithm (ASIR-V). Median radiation dose is about 0.5 mSv, range between about 0.2 and 1.2 mSv; median contrast agent administration about 45 mL, range between 35 and 55 mL.
The experimental intervention is an additional CT scan with a lower dose (about 20 to 50% decrease) and a similar contrast agent administration that is reconstructed with a deep-learning image reconstruction immediately after the clinical CT scan. The additional time required is about 5 minutes.
|
|---|---|
|
Overall Study
STARTED
|
50
|
|
Overall Study
COMPLETED
|
50
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Deep-Learning Image Reconstruction in CCTA
Baseline characteristics by cohort
| Measure |
Normal-dose Versus Low-dose
n=50 Participants
The standard intervention consists of the routinely performed cardiac CT datasets reconstructed with a standard iterative reconstruction algorithm (ASIR-V). Median radiation dose is about 0.5 mSv, range between about 0.2 and 1.2 mSv; median contrast agent administration about 45 mL, range between 35 and 55 mL.
The experimental intervention is an additional CT scan with a lower dose (about 20 to 50% decrease) and a similar contrast agent administration that is reconstructed with a deep-learning image reconstruction immediately after the clinical CT scan. The additional time required is about 5 minutes.
|
|---|---|
|
Age, Continuous
|
59 years
STANDARD_DEVIATION 1 • n=5 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
43 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
50 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
Switzerland
|
50 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Day 1Subjective image quality as measured by Likert scale from 1 (non-evaluable) to 5 (excellent)
Outcome measures
| Measure |
Normal-dose Versus Low-dose
n=50 Participants
The standard intervention consists of the routinely performed cardiac CT datasets reconstructed with a standard iterative reconstruction algorithm (ASIR-V). Median radiation dose is about 0.5 mSv, range between about 0.2 and 1.2 mSv; median contrast agent administration about 45 mL, range between 35 and 55 mL.
The experimental intervention is an additional CT scan with a lower dose (about 20 to 50% decrease) and a similar contrast agent administration that is reconstructed with a deep-learning image reconstruction immediately after the clinical CT scan. The additional time required is about 5 minutes.
|
|---|---|
|
Subjective Image Quality
Low-Dose
|
5 Score on a Likert scale (0-5) 5=best
Standard Deviation 0
|
|
Subjective Image Quality
Normal-Dose
|
5 Score on a Likert scale (0-5) 5=best
Standard Deviation 0
|
SECONDARY outcome
Timeframe: Day 1Signal intensity as average hounsfield units within a region of interest in the aortic root, change from experimental interventional to the control intervention
Outcome measures
| Measure |
Normal-dose Versus Low-dose
n=50 Participants
The standard intervention consists of the routinely performed cardiac CT datasets reconstructed with a standard iterative reconstruction algorithm (ASIR-V). Median radiation dose is about 0.5 mSv, range between about 0.2 and 1.2 mSv; median contrast agent administration about 45 mL, range between 35 and 55 mL.
The experimental intervention is an additional CT scan with a lower dose (about 20 to 50% decrease) and a similar contrast agent administration that is reconstructed with a deep-learning image reconstruction immediately after the clinical CT scan. The additional time required is about 5 minutes.
|
|---|---|
|
Signal Intensity
Low-Dose
|
462 Hounsfield units
Standard Deviation 76
|
|
Signal Intensity
Normal Dose
|
443 Hounsfield units
Standard Deviation 85
|
SECONDARY outcome
Timeframe: Day 1Image noise as standard deviation of hounsfield units within a region of interest in the aortic root, change from experimental interventional to the control intervention
Outcome measures
| Measure |
Normal-dose Versus Low-dose
n=50 Participants
The standard intervention consists of the routinely performed cardiac CT datasets reconstructed with a standard iterative reconstruction algorithm (ASIR-V). Median radiation dose is about 0.5 mSv, range between about 0.2 and 1.2 mSv; median contrast agent administration about 45 mL, range between 35 and 55 mL.
The experimental intervention is an additional CT scan with a lower dose (about 20 to 50% decrease) and a similar contrast agent administration that is reconstructed with a deep-learning image reconstruction immediately after the clinical CT scan. The additional time required is about 5 minutes.
|
|---|---|
|
Image Noise
Low-Dose
|
27 Hounsfield units
Standard Deviation 4
|
|
Image Noise
Normal-Dose
|
28 Hounsfield units
Standard Deviation 6
|
SECONDARY outcome
Timeframe: Day 1Signal-to-noise ratio
Outcome measures
| Measure |
Normal-dose Versus Low-dose
n=50 Participants
The standard intervention consists of the routinely performed cardiac CT datasets reconstructed with a standard iterative reconstruction algorithm (ASIR-V). Median radiation dose is about 0.5 mSv, range between about 0.2 and 1.2 mSv; median contrast agent administration about 45 mL, range between 35 and 55 mL.
The experimental intervention is an additional CT scan with a lower dose (about 20 to 50% decrease) and a similar contrast agent administration that is reconstructed with a deep-learning image reconstruction immediately after the clinical CT scan. The additional time required is about 5 minutes.
|
|---|---|
|
Signal-to-noise Ratio
Low-Dose
|
17 Ratio
Standard Deviation 3
|
|
Signal-to-noise Ratio
Normal-Dose
|
16 Ratio
Standard Deviation 2
|
SECONDARY outcome
Timeframe: Day 1Comparison of dose-length products
Outcome measures
| Measure |
Normal-dose Versus Low-dose
n=50 Participants
The standard intervention consists of the routinely performed cardiac CT datasets reconstructed with a standard iterative reconstruction algorithm (ASIR-V). Median radiation dose is about 0.5 mSv, range between about 0.2 and 1.2 mSv; median contrast agent administration about 45 mL, range between 35 and 55 mL.
The experimental intervention is an additional CT scan with a lower dose (about 20 to 50% decrease) and a similar contrast agent administration that is reconstructed with a deep-learning image reconstruction immediately after the clinical CT scan. The additional time required is about 5 minutes.
|
|---|---|
|
Dose-length Products
Low-Dose
|
31 mGy*cm
Interval 25.0 to 34.0
|
|
Dose-length Products
Normal-Dose
|
52 mGy*cm
Interval 42.0 to 58.0
|
SECONDARY outcome
Timeframe: Day 1Quantitative analysis of coronary artery plaque volumes
Outcome measures
| Measure |
Normal-dose Versus Low-dose
n=50 Participants
The standard intervention consists of the routinely performed cardiac CT datasets reconstructed with a standard iterative reconstruction algorithm (ASIR-V). Median radiation dose is about 0.5 mSv, range between about 0.2 and 1.2 mSv; median contrast agent administration about 45 mL, range between 35 and 55 mL.
The experimental intervention is an additional CT scan with a lower dose (about 20 to 50% decrease) and a similar contrast agent administration that is reconstructed with a deep-learning image reconstruction immediately after the clinical CT scan. The additional time required is about 5 minutes.
|
|---|---|
|
Plaque Volumes
Low-Dose
|
12.42 mm^3
Standard Deviation 13.14
|
|
Plaque Volumes
Normal-Dose
|
13.84 mm^3
Standard Deviation 14.41
|
Adverse Events
Low-dose
Normal-dose
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place